[Anti-platelets without a bleeding risk: novel targets and strategies].


Anti-platelet agents such as aspirin, clopidogrel and antagonists of integrin αIIbβ3 allowed to efficiently reduce morbidity and mortality associated with arterial thrombosis. A major limit of these drugs is that they increase the risk of bleeding. During the last few years, several innovative anti-thrombotic strategies with a potentially low bleeding risk… (More)
DOI: 10.1051/jbio/2015023


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics